Publication:

Two minor NQO1 and NQO2 alleles predict poor response of breast cancer patients to adjuvant doxorubicin and cyclophosphamide therapy (2011)

Author(s): Jamieson D, Cresti N, Bray J, Sludden J, Griffin MJ, Hawsawi NM, Famie E, Mould EVA, Verrill MW, May FEB, Boddy AV

      • Date: 01-12-2011
      • Journal: Pharmacogenetics and Genomics
      • Volume: 21
      • Issue: 12
      • Pages: 808-819
      • Publisher: Lippincott Williams & Wilkins
      • Publication type: Article
      • Bibliographic status: Published

      Keywords: cancer doxorubicin NAD(P)H dehydrogenase (quinone) pharmacogenetics tamoxifen XENOBIOTIC-METABOLIZING ENZYMES ACUTE LYMPHOBLASTIC-LEUKEMIA ACUTE MYELOID-LEUKEMIA DT-DIAPHORASE PROTEASOMAL DEGRADATION GENE-EXPRESSION NQO1-ASTERISK-2 POLYMORPHISM QUINONE OXIDOREDUCTASE-1 ASSOCIATION P53

      Staff

      Professor Alan Boddy
      Professor of Cancer Pharmacology

      Dr Felicity May
      Senior Lecturer